<DOC>
	<DOCNO>NCT02983162</DOCNO>
	<brief_summary>Rationale : Retrospectively review participant GODDAF database , reveal significant association weight genetic risk score Dupuytren disease recurrence . However , significant dose-response relation find . This might cause underestimating recurrence rate , due retrospective nature determine recurrence . Therefore , want follow-up measurement GODDAF participant , see whether suffered recurrent disease . Objective : We aim determine whether wGRS associate recurrent DD . Study design : An observational study , participant GODDAF study follow . Study population : Patients affect Dupuytren disease , age 18-96 year , previously include another study genetic basis Dupuytren disease . Intervention ( applicable ) : NA Main study parameters/endpoints : The main study parameter presence recurrent Dupuytren disease .</brief_summary>
	<brief_title>Is wGRS Associated With DD Recurrence ?</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Dupuytren Contracture</mesh_term>
	<criteria>DD patient participant GODDAF study genetic data pass quality control surgical treatment DD write informed consent Decisionally incapacitate Patients treated DD collagenase radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>